Jonathan D. Lee - Concepedia

Concepedia

Author

Jonathan D. Lee

Beth Israel Deaconess Medical Center ORCID

Also Known As

Jonathan D Lee, Jonathan D. Lee, Jonathan David Lee, Jonathan Lee

28

Publications

1.2K

Citations

10

H-Index

40

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Harvard University Brigham and Women's Hospital University of Turin Boston Children's Hospital

JD

About

Jonathan D. Lee is an author at Beth Israel Deaconess Medical Center specializing in medicine, gene expression, and epidemiology of aging.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	684
2	Health Sciences	1	1	22
3	Natural Sciences	1	1	127
4	Cell Biology	1	1	65
5	Epidemiology	1	1	22

Jonathan D. Lee

×

10

Publications

1.2K

Citations

10

H-Index

	Year	Citations
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway Yu-Ru Lee, Ming Chen, Jonathan D. Lee, Science	2019	329
An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance Assaf C. Bester, Jonathan D. Lee, Alejandro Chavez, Cell Functionalize LncrnasMolecular BiologyLong Non-coding RnaGene EditingGenome Editing	2018	326
Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci Clint L. Miller, Milos Pjanic, Ting Wang, Nature Communications	2016	140
Germline NPM1 mutations lead to altered rRNA 2′-O-methylation and cause dyskeratosis congenita Daphna Nachmani, Anne Bothmer, Silvia Grisendi, Nature Genetics Genetic DisorderMedicineGeneticsDyskeratosis CongenitaNatural Sciences	2019	127
Severe COVID-19 is associated with molecular signatures of aging in the human brain Maria Mavrikaki, Jonathan D. Lee, Isaac H. Solomon, Nature Aging Neurodegenerative DiseasesAgingNeurovirologyMedicineCovid-19 Pandemic	2022	100
Zinc Finger Protein SALL4 Functions through an AT-Rich Motif to Regulate Gene Expression Nikki R. Kong, Mahmoud A. Bassal, Hong Kee Tan, Cell Reports Molecular RegulationGeneticsAt-rich MotifEpigeneticsTranscriptional Regulation	2021	65
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy Vera Mugoni, Riccardo Panella, Giulia Cheloni, Cell Research PharmacologyPharmacotherapyMedicineDrug Discovery	2019	44
Genetic fusions favor tumorigenesis through degron loss in oncogenes Jing Liu, Collin Tokheim, Jonathan D. Lee, Nature Communications	2021	37
Severe COVID-19 induces molecular signatures of aging in the human brain Maria Mavrikaki, Jonathan D. Lee, Isaac H. Solomon, AgingImmunologyBiogerontologyEpidemiology Of AgingCovid-19	2021	22
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53 Jonathan D. Lee, Bridget L. Menasché, Maria Mavrikaki, Cell Reports	2023	11

Page 1